Thank you to Dr John Ridley, Metrion Biosciences’ Business Manager for writing this article and to MedNous for publishing this work. This article was published in the June 2020 edition of MedNous, a publication of Evernow Publishing Ltd. […]
Metrion Biosciences and International Scientific Consortium publish data and new recommendations for in vitro risk assessment of the cardiac safety of new medicines Part of the US FDA’s Comprehensive in vitro Proarrythmia Assay (CiPA) Initiative Cambridge, UK, 07 April 2020: Metrion Biosciences Limited (Metrion), the specialist ion channel CRO and drug discovery company, today [...]
Metrion Biosciences' Business Manager Dr John Ridley, Head of Client Research Services, Dr Robert Kirby and Senior Scientist, Dr Edward Humphries will be attending, presenting posters and exhibiting at the Safety Pharmacology Society (SPS) Annual Meeting. The event is to be held at the Centre de Convencions Internacional de Barcelona between 23rd and 26th September [...]
Metrion Biosciences will be hosting a Company Showcase at the Cambridge Building (main Cafe) at the Babraham Research Campus, from 10am until 4pm on Thursday 27th June 2019. Metrion will have a tabletop booth with literature, promotional gifts and stationary and plenty of information about Metrion's range of ion channel drug discovery services. Metrion's staff [...]
AstraZeneca and Metrion Biosciences again joined forces on April 9 to co-host the 6th Cambridge Ion Channel Forum, held at the Milstein building at Granta Park. The event has been a key feature of the ion channel enthusiasts’ calendar since 2011 and attended by around 65 delegates, who also enjoyed a networking lunch and poster [...]
Metrion Biosciences and Axol Bioscience joined forces on Wednesday 23rd May to co-host the 2018 “Interactive Stem Cell Forum” in Cambridge (UK). A meeting featuring a morning of informative and thought-provoking talks from leading academic and industry-based researchers working in the stem cell field, followed by an afternoon [...]
